Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts2Massachusetts General Hospital, Boston3National Bureau of Economic Research, Cambridge, Massachusetts.
Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
JAMA Intern Med. 2015 Feb;175(2):237-44. doi: 10.1001/jamainternmed.2014.6781.
Thousands of physicians attend scientific meetings annually. Although hospital physician staffing and composition may be affected by meetings, patient outcomes and treatment patterns during meeting dates are unknown.
To analyze mortality and treatment differences among patients admitted with acute cardiovascular conditions during dates of national cardiology meetings compared with nonmeeting dates.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective analysis of 30-day mortality among Medicare beneficiaries hospitalized with acute myocardial infarction (AMI), heart failure, or cardiac arrest from 2002 through 2011 during dates of 2 national cardiology meetings compared with identical nonmeeting days in the 3 weeks before and after conferences (AMI, 8570 hospitalizations during 82 meeting days and 57,471 during 492 nonmeeting days; heart failure, 19,282 during meeting days and 11,4591 during nonmeeting days; cardiac arrest, 1564 during meeting days and 9580 during nonmeeting days). Multivariable analyses were conducted separately for major teaching hospitals and nonteaching hospitals and for low- and high-risk patients. Differences in treatment utilization were assessed.
Hospitalization during cardiology meeting dates.
Thirty-day mortality, procedure rates, charges, length of stay.
Patient characteristics were similar between meeting and nonmeeting dates. In teaching hospitals, adjusted 30-day mortality was lower among high-risk patients with heart failure or cardiac arrest admitted during meeting vs nonmeeting dates (heart failure, 17.5% [95% CI, 13.7%-21.2%] vs 24.8% [95% CI, 22.9%-26.6%]; P < .001; cardiac arrest, 59.1% [95% CI, 51.4%-66.8%] vs 69.4% [95% CI, 66.2%-72.6%]; P = .01). Adjusted mortality for high-risk AMI in teaching hospitals was similar between meeting and nonmeeting dates (39.2% [95% CI, 31.8%-46.6%] vs 38.5% [95% CI, 35.0%-42.0%]; P = .86), although adjusted percutaneous coronary intervention (PCI) rates were lower during meetings (20.8% vs 28.2%; P = .02). No mortality or utilization differences existed for low-risk patients in teaching hospitals or high- or low-risk patients in nonteaching hospitals. In sensitivity analyses, cardiac mortality was not affected by hospitalization during oncology, gastroenterology, and orthopedics meetings, nor was gastrointestinal hemorrhage or hip fracture mortality affected by hospitalization during cardiology meetings.
High-risk patients with heart failure and cardiac arrest hospitalized in teaching hospitals had lower 30-day mortality when admitted during dates of national cardiology meetings. High-risk patients with AMI admitted to teaching hospitals during meetings were less likely to receive PCI, without any mortality effect.
每年都有成千上万的医生参加科学会议。尽管医院的医生人员配备和构成可能会受到会议的影响,但会议期间患者的预后和治疗模式尚不清楚。
分析与非会议日相比,在全国心脏病学会议期间因急性心血管疾病入院的患者的死亡率和治疗差异。
设计、设置和参与者:回顾性分析 2002 年至 2011 年期间,30 天内因急性心肌梗死(AMI)、心力衰竭或心搏骤停在全国心脏病学会议期间(AMI 期间为 8570 例住院患者,82 个会议日和 57471 例非会议日;心力衰竭,19282 例会议日和 114591 例非会议日;心搏骤停,1564 例会议日和 9580 例非会议日)与会议前和会议后 3 周相同非会议日(AMI 期间为 8570 例住院患者,82 个会议日和 57471 例非会议日;心力衰竭,19282 例会议日和 114591 例非会议日;心搏骤停,1564 例会议日和 9580 例非会议日)期间接受治疗的 Medicare 受益人 30 天死亡率。分别对主要教学医院和非教学医院以及低危和高危患者进行了多变量分析。评估了治疗利用的差异。
心脏病学会议期间的住院治疗。
30 天死亡率、手术率、费用、住院时间。
会议日和非会议日之间患者的特征相似。在教学医院中,与非会议日相比,高危心力衰竭或心搏骤停患者在会议期间的 30 天死亡率较低(心力衰竭,17.5%[95%CI,13.7%-21.2%]vs 24.8%[95%CI,22.9%-26.6%];P<0.001;心搏骤停,59.1%[95%CI,51.4%-66.8%]vs 69.4%[95%CI,66.2%-72.6%];P=0.01)。教学医院高危 AMI 患者的调整死亡率在会议日和非会议日之间相似(39.2%[95%CI,31.8%-46.6%]vs 38.5%[95%CI,35.0%-42.0%];P=0.86),尽管会议期间经皮冠状动脉介入治疗(PCI)的调整率较低(20.8%vs 28.2%;P=0.02)。教学医院低危患者或非教学医院高低危患者之间没有死亡率或利用差异。在敏感性分析中,在肿瘤学、胃肠病学和骨科会议期间住院不会影响心脏性死亡,在心脏病学会议期间住院也不会影响胃肠道出血或髋部骨折死亡率。
在教学医院住院的高危心力衰竭和心搏骤停患者,在全国心脏病学会议期间住院的 30 天死亡率较低。在会议期间,教学医院收治的高危 AMI 患者接受 PCI 的可能性较低,但死亡率无影响。